This study will compare the response of subjects who failed a first-line ATV-containing regimen and who have the 150L-containing virus to subsequent protease inhibitor (PI)-containing therapy with that of a cohort who has failed a first-line reverse transcriptase inhibitor (NNRTI), and is subsequently receiving PI-containing therapy.
Name: LPV/RTV + 2NRTIs
Description: Tablets, Oral, Variable, Twice daily, 48 weeks.Type: DrugA1
Name: LPV/RTV + 2NRTIs
Description: Tablets, Oral, Variable, Twice daily, 48 weeks.Type: DrugA2
Cohort
There is one SNP
An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response. --- I50L ---